Table 1.
Variables | Elderly (≥70 years) (n=111) |
Younger (<70 years) (n=901) |
p-value |
---|---|---|---|
Gender, male | 81 (73.0%) | 619 (68.7%) | 0.358 |
Body mass index | 23.5±3.6 | 22.8±3.2 | 0.215 |
Child–Pugh class | 0.001 | ||
A | 61 (55.0%) | 642 (71.3%) | |
B | 50 (45.0%) | 259 (28.7%) | |
Smoking history | 36 (32.4%) | 347 (38.5%) | 0.215 |
Diabetes | 18 (16.2%) | 76 (8.4%) | 0.014 |
Cardiovascular disease | 44 (39.6%) | 128 (14.2%) | <0.001 |
ASA score | 0.001 | ||
I | 5 (4.5%) | 29 (3.2%) | |
II | 68 (61.3%) | 696 (77.2%) | |
III | 38 (34.2%) | 176 (19.5%) | |
Hepatitis B and/or C | 19 (17.1%) | 423 (46.9%) | <0.001 |
Alanine aminotransferase (U/L) | 97.9±114.8 | 91.6±129.8 | 0.623 |
Aspartate aminotransferase (U/L) | 92.0±90.6 | 82.2±104.7 | 0.342 |
Total bilirubin (µmol/L) | 105.1±125.7 | 65.9±107.4 | 0.003 |
Albumin (g/L) | 36.8±6.5 | 38.4±5.2 | 0.003 |
White blood cells (×109/L) | 6.5±2.6 | 6.0±2.7 | 0.029 |
Hemoglobin (g/L) | 122.3±17.6 | 128.8±19.4 | 0.001 |
Platelet (×109/L) | 179.5±66.3 | 173.3±85.9 | 0.112 |
Operation time (min) | 268±64 | 261±83 | 0.082 |
Blood loss (mL) | 541.9±459.4 | 678.9±751.1 | 0.061 |
Intraoperative transfusion | 46 (41.4%) | 413 (45.8%) | 0.419 |
Pathological diagnosis | |||
Liver disease | 0.166 | ||
Hepatocellular carcinoma | 37 (33.3%) | 479 (53.2%) | |
Intrahepatic cholangiocarcinoma | 8 (7.2%) | 50 (5.5%) | |
Metastatic tumors | 4 (3.6%) | 32 (3.6%) | |
Pancreas disease | 0.656 | ||
Adenocarcinoma | 58 (52.3%) | 295 (32.7%) | |
Benign/borderline tumors | 4 (3.6%) | 45 (5.0%) | |
Surgical procedures | <0.001 | ||
Hepatectomy | 49 (44.1%) | 561 (62.3%) | |
Pancreaticoduodenectomy | 62 (55.9%) | 340 (37.7%) | |
Types of hepatectomy | 0.818 | ||
Major hepatectomy | 15 (30.6%) | 163 (29.1%) | |
Minor hepatectomy | 34 (69.4%) | 398 (70.9%) | |
Vascular resection | 4 (3.6%) | 60 (6.7%) | 0.298 |
Note: Continuous variables are expressed as mean ± SD and categorical variables as number (percentage).
Abbreviation: ASA, American Society of Anesthesiologists.